Between 2015 and 2021, 33 biosimilars of 11 biologic drugs received FDA approval. Two-thirds of the biosimilars had skinny labels, according to the study. Among 21 biosimilars marketed before 2022, 13 had skinny labels.
Between 2015 and 2021, 33 biosimilars of 11 biologic drugs received FDA approval. Two-thirds of the biosimilars had skinny labels, according to the study. Among 21 biosimilars marketed before 2022, 13 had skinny labels.
Between 2015 and 2021, 33...